应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BCEL Atreca, Inc.
盘后交易 11-26 16:00:00 EST 延时
资讯
新帖
简况
Atreca, Inc.盘中异动 股价大跌5.53%报0.188美元
自选股智能写手 · 03-15
Atreca, Inc.盘中异动 股价大跌5.53%报0.188美元
Atreca, Inc.盘中异动 急速上涨5.11%
自选股智能写手 · 03-14
Atreca, Inc.盘中异动 急速上涨5.11%
Atreca, Inc.盘中异动 早盘股价大涨6.64%
自选股智能写手 · 03-13
Atreca, Inc.盘中异动 早盘股价大涨6.64%
Atreca, Inc.盘中异动 早盘急速下跌6.60%报0.198美元
自选股智能写手 · 03-12
Atreca, Inc.盘中异动 早盘急速下跌6.60%报0.198美元
Atreca, Inc.盘中异动 早盘股价大跌5.09%报0.213美元
自选股智能写手 · 03-11
Atreca, Inc.盘中异动 早盘股价大跌5.09%报0.213美元
Atreca, Inc.盘中异动 下午盘大幅下跌5.22%报0.234美元
自选股智能写手 · 03-07
Atreca, Inc.盘中异动 下午盘大幅下跌5.22%报0.234美元
Atreca, Inc.盘中异动 大幅下跌5.06%报0.240美元
自选股智能写手 · 03-06
Atreca, Inc.盘中异动 大幅下跌5.06%报0.240美元
Atreca, Inc.盘中异动 早盘大幅跳水6.64%报0.253美元
自选股智能写手 · 03-04
Atreca, Inc.盘中异动 早盘大幅跳水6.64%报0.253美元
Atreca Inc盘中异动 早盘股价大跌5.80%
自选股智能写手 · 02-27
Atreca Inc盘中异动 早盘股价大跌5.80%
Atreca Inc盘中异动 急速下跌7.61%
自选股智能写手 · 02-23
Atreca Inc盘中异动 急速下跌7.61%
Atreca Inc盘中异动 大幅下挫5.42%报0.293美元
自选股智能写手 · 02-20
Atreca Inc盘中异动 大幅下挫5.42%报0.293美元
Atreca Inc盘中异动 早盘快速上涨7.27%
自选股智能写手 · 02-15
Atreca Inc盘中异动 早盘快速上涨7.27%
Atreca Inc盘中异动 大幅拉升5.28%报0.265美元
自选股智能写手 · 02-14
Atreca Inc盘中异动 大幅拉升5.28%报0.265美元
Atreca Inc盘中异动 早盘股价大涨5.32%
自选股智能写手 · 02-07
Atreca Inc盘中异动 早盘股价大涨5.32%
Atreca Inc盘中异动 早盘大幅下跌5.05%报0.261美元
自选股智能写手 · 02-06
Atreca Inc盘中异动 早盘大幅下跌5.05%报0.261美元
Atreca Inc盘中异动 股价大跌5.24%
自选股智能写手 · 02-01
Atreca Inc盘中异动 股价大跌5.24%
Atreca Inc盘中异动 早盘快速下跌7.78%报0.307美元
自选股智能写手 · 01-30
Atreca Inc盘中异动 早盘快速下跌7.78%报0.307美元
Atreca Inc盘中异动 股价大涨5.88%报0.234美元
自选股智能写手 · 01-25
Atreca Inc盘中异动 股价大涨5.88%报0.234美元
Atreca Inc盘中异动 早盘股价大跌6.31%报0.244美元
自选股智能写手 · 01-23
Atreca Inc盘中异动 早盘股价大跌6.31%报0.244美元
Atreca Inc盘中异动 股价大跌6.00%报0.282美元
自选股智能写手 · 01-22
Atreca Inc盘中异动 股价大跌6.00%报0.282美元
公司概况
公司名称:
Atreca, Inc.
所属市场:
PINK
上市日期:
--
主营业务:
Atreca, Inc.于2010年6月11日在特拉华州注册成立。该公司是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫治疗剂,以治疗多种实体肿瘤类型。该公司的主要候选产品ATRC-101是一种临床前开发的单克隆抗体,具有新的作用机制和源自使用其发现平台鉴定的抗体的靶标。自成立以来,公司主要从事研发,筹集资金,建立管理团队和建立知识产权组合。
发行价格:
--
{"stockData":{"symbol":"BCEL","market":"US","secType":"STK","nameCN":"Atreca, Inc.","latestPrice":0.09,"timestamp":1732654800000,"preClose":0.09,"halted":0,"volume":0,"delay":15,"floatShares":27556790,"shares":32908634,"eps":-2.495705,"marketStatus":"盘后交易","marketStatusCode":4,"change":0,"latestTime":"11-26 16:00:00 EST 延时","open":0.09,"high":0.09,"low":0.09,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-2.495705,"exchange":"PINK","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732669200000},"adr":0,"adjPreClose":0.09,"volumeRatio":0},"requestUrl":"/m/hq/s/BCEL/wiki","defaultTab":"wiki","newsList":[{"id":"2419905400","title":"Atreca, Inc.盘中异动 股价大跌5.53%报0.188美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419905400","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2419905400?lang=zh_cn&edition=full","pubTime":"2024-03-15 22:57","pubTimestamp":1710514662,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日22时57分,Atreca, Inc.股票出现异动,股价急速下挫5.53%。截至发稿,该股报0.188美元/股,成交量7.4087万股,换手率0.19%,振幅5.03%。Atreca, Inc.股票所在的生物技术行业中,整体跌幅为0.24%。Atreca, Inc.公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152257437a4d17c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152257437a4d17c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCEL","BK4139"],"gpt_icon":0},{"id":"2419604888","title":"Atreca, Inc.盘中异动 急速上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419604888","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2419604888?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:31","pubTimestamp":1710423087,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时31分,Atreca, Inc.股票出现异动,股价急速拉升5.11%。Atreca, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。其相关个股中,知临集团、180 Life Sciences Corp C/Wts 07/11/2025、Nuvectis Pharma, Inc.涨幅较大,Novabay Pharmaceuticals, Inc.、Gri Bio, Inc.、知临集团较为活跃,换手率分别为115.77%、58.29%、57.60%,振幅较大的相关个股有知临集团、Renovorx, Inc.、Codexis, Inc.,振幅分别为16.17%、14.40%、8.58%。Atreca, Inc.公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142131278b32f47a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142131278b32f47a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCEL"],"gpt_icon":0},{"id":"2419687698","title":"Atreca, Inc.盘中异动 早盘股价大涨6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419687698","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2419687698?lang=zh_cn&edition=full","pubTime":"2024-03-13 21:58","pubTimestamp":1710338282,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日21时58分,Atreca, Inc.股票出现波动,股价大幅拉升6.64%。截至发稿,该股报0.180美元/股,成交量45.6801万股,换手率1.15%,振幅7.64%。Atreca, Inc.股票所在的生物技术行业中,整体跌幅为0.03%。Atreca, Inc.公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313215802877ce401&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313215802877ce401&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCEL"],"gpt_icon":0},{"id":"2418329405","title":"Atreca, Inc.盘中异动 早盘急速下跌6.60%报0.198美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418329405","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2418329405?lang=zh_cn&edition=full","pubTime":"2024-03-12 21:31","pubTimestamp":1710250311,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日21时31分,Atreca, Inc.股票出现异动,股价急速下跌6.60%。截至发稿,该股报0.198美元/股,成交量11.8579万股,换手率0.30%,振幅3.58%。Atreca, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。Atreca, Inc.公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122131517919bb43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122131517919bb43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCEL","BK4139"],"gpt_icon":0},{"id":"2418335723","title":"Atreca, Inc.盘中异动 早盘股价大跌5.09%报0.213美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418335723","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2418335723?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:31","pubTimestamp":1710163860,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时31分,Atreca, Inc.股票出现异动,股价大幅跳水5.09%。截至发稿,该股报0.213美元/股,成交量1463股,换手率0.00%,振幅0.00%。Atreca, Inc.股票所在的生物技术行业中,整体涨幅为0.12%。Atreca, Inc.公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031121310187e77c2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031121310187e77c2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCEL"],"gpt_icon":0},{"id":"2417035244","title":"Atreca, Inc.盘中异动 下午盘大幅下跌5.22%报0.234美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417035244","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2417035244?lang=zh_cn&edition=full","pubTime":"2024-03-07 04:04","pubTimestamp":1709755455,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日04时04分,Atreca, Inc.股票出现异动,股价大幅跳水5.22%。截至发稿,该股报0.234美元/股,成交量31.1114万股,换手率0.79%,振幅6.03%。Atreca, Inc.股票所在的生物技术行业中,整体涨幅为0.26%。Atreca, Inc.公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403070404157a4a2aac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403070404157a4a2aac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCEL"],"gpt_icon":0},{"id":"2417034446","title":"Atreca, Inc.盘中异动 大幅下跌5.06%报0.240美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417034446","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2417034446?lang=zh_cn&edition=full","pubTime":"2024-03-06 00:15","pubTimestamp":1709655312,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日00时15分,Atreca, Inc.股票出现波动,股价大幅下挫5.06%。截至发稿,该股报0.240美元/股,成交量24.024万股,换手率0.61%,振幅6.92%。Atreca, Inc.股票所在的生物技术行业中,整体跌幅为1.61%。Atreca, Inc.公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030600151379178666&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030600151379178666&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCEL","BK4139"],"gpt_icon":0},{"id":"2416447631","title":"Atreca, Inc.盘中异动 早盘大幅跳水6.64%报0.253美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416447631","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2416447631?lang=zh_cn&edition=full","pubTime":"2024-03-04 22:31","pubTimestamp":1709562669,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日22时31分,Atreca, Inc.股票出现波动,股价快速下挫6.64%。截至发稿,该股报0.253美元/股,成交量3.2347万股,换手率0.08%,振幅0.00%。Atreca, Inc.股票所在的生物技术行业中,整体涨幅为0.56%。Atreca, Inc.公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042231098b026261&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042231098b026261&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCEL","BK4139"],"gpt_icon":0},{"id":"2414056528","title":"Atreca Inc盘中异动 早盘股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414056528","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2414056528?lang=zh_cn&edition=full","pubTime":"2024-02-27 22:35","pubTimestamp":1709044513,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日22时35分,Atreca Inc股票出现异动,股价快速下跌5.80%。Atreca Inc股票所在的生物技术行业中,整体跌幅为0.45%。其相关个股中,Janux Therapeutics Inc、Viking Therapeutics Inc、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大,Scisparc Ltd、Zyversa Therapeutics Inc、Galera Therapeutics Inc较为活跃,换手率分别为321.21%、88.46%、29.77%,振幅较大的相关个股有Janux Therapeutics Inc、Viking Therapeutics Inc、Fate Therapeutics,振幅分别为36.62%、25.26%、17.84%。Atreca Inc公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240227223514861d8db3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240227223514861d8db3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCEL","BK4139"],"gpt_icon":0},{"id":"2413767902","title":"Atreca Inc盘中异动 急速下跌7.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413767902","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2413767902?lang=zh_cn&edition=full","pubTime":"2024-02-23 22:40","pubTimestamp":1708699239,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日22时40分,Atreca Inc股票出现波动,股价急速下跌7.61%。Atreca Inc股票所在的生物技术行业中,整体涨幅为0.65%。其相关个股中,Ocean Biomedical Inc、Maravai Lifesciences Hldgs Inc、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,Enveric Biosciences Inc、Biodexa Pharmaceuticals Plc、Clearmind Medicine Inc较为活跃,换手率分别为280.92%、117.60%、95.58%,振幅较大的相关个股有Ocean Biomedical Inc、Ocean Biomedical Inc C/Wts 14/02/2028 、Biodexa Pharmaceuticals Plc,振幅分别为52.58%、25.00%、20.78%。Atreca Inc公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240223224039861d7eb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240223224039861d7eb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCEL","BK4139"],"gpt_icon":0},{"id":"2412378105","title":"Atreca Inc盘中异动 大幅下挫5.42%报0.293美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2412378105","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2412378105?lang=zh_cn&edition=full","pubTime":"2024-02-20 22:32","pubTimestamp":1708439539,"startTime":"0","endTime":"0","summary":"北京时间2024年02月20日22时32分,Atreca Inc股票出现异动,股价急速下挫5.42%。截至发稿,该股报0.293美元/股,成交量3.998万股,换手率0.10%,振幅3.29%。Atreca Inc股票所在的生物技术行业中,整体涨幅为0.36%。Atreca Inc公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022022321981a00d73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022022321981a00d73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCEL","BK4139"],"gpt_icon":0},{"id":"2411541543","title":"Atreca Inc盘中异动 早盘快速上涨7.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411541543","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2411541543?lang=zh_cn&edition=full","pubTime":"2024-02-15 22:33","pubTimestamp":1708007622,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日22时33分,Atreca Inc股票出现异动,股价大幅拉升7.27%。Atreca Inc股票所在的生物技术行业中,整体涨幅为0.36%。其相关个股中,Coeptis Therapeutics Holdings Inc、Orgenesis Inc、Clene Inc C/Wts 30/12/2025 涨幅较大,Kintara Therapeutics Inc、Adial Pharmaceuticals Inc、Jaguar Health Inc较为活跃,换手率分别为25.25%、16.68%、11.72%,振幅较大的相关个股有Sol Gel Technologies Ltd、Coeptis Therapeutics Holdings Inc、Adaptive Biotechnologies Corp,振幅分别为16.67%、14.42%、13.96%。Atreca Inc公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021522334387e7030e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021522334387e7030e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCEL","BK4139"],"gpt_icon":0},{"id":"2411304074","title":"Atreca Inc盘中异动 大幅拉升5.28%报0.265美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411304074","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2411304074?lang=zh_cn&edition=full","pubTime":"2024-02-14 22:30","pubTimestamp":1707921036,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日22时30分,Atreca Inc股票出现波动,股价快速上涨5.28%。截至发稿,该股报0.265美元/股,成交量3.3873万股,换手率0.09%,振幅3.18%。Atreca Inc股票所在的生物技术行业中,整体涨幅为0.00%。Atreca Inc公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021422303687e700e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021422303687e700e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCEL","BK4139"],"gpt_icon":0},{"id":"2409227002","title":"Atreca Inc盘中异动 早盘股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409227002","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2409227002?lang=zh_cn&edition=full","pubTime":"2024-02-07 22:32","pubTimestamp":1707316356,"startTime":"0","endTime":"0","summary":"北京时间2024年02月07日22时32分,Atreca Inc股票出现异动,股价快速上涨5.32%。Atreca Inc股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Biodexa Pharmaceuticals Plc、Jasper Therapeutics Inc C/Wts 24/09/2026 、Invivo Therapeutics Holding Corp涨幅较大,Biodexa Pharmaceuticals Plc、Invivo Therapeutics Holding Corp、Altamira Therapeutics Ltd较为活跃,换手率分别为133.63%、77.50%、38.67%,振幅较大的相关个股有Invivo Therapeutics Holding Corp、Viracta Therapeutics Inc、Equillium Inc,振幅分别为25.00%、12.94%、12.14%。Atreca Inc公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020722323687e6ed93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020722323687e6ed93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCEL","BK4139"],"gpt_icon":0},{"id":"2409434564","title":"Atreca Inc盘中异动 早盘大幅下跌5.05%报0.261美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409434564","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2409434564?lang=zh_cn&edition=full","pubTime":"2024-02-06 00:06","pubTimestamp":1707149207,"startTime":"0","endTime":"0","summary":"北京时间2024年02月06日00时06分,Atreca Inc股票出现异动,股价大幅跳水5.05%。截至发稿,该股报0.261美元/股,成交量36.8504万股,换手率0.93%,振幅6.80%。Atreca Inc股票所在的生物技术行业中,整体涨幅为0.25%。Atreca Inc公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020600064787e6d0a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020600064787e6d0a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCEL"],"gpt_icon":0},{"id":"2408632490","title":"Atreca Inc盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2408632490","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2408632490?lang=zh_cn&edition=full","pubTime":"2024-02-01 23:14","pubTimestamp":1706800487,"startTime":"0","endTime":"0","summary":"北京时间2024年02月01日23时14分,Atreca Inc股票出现异动,股价快速跳水5.24%。Atreca Inc股票所在的生物技术行业中,整体涨幅为0.07%。其相关个股中,Neurobo Pharmaceuticals Inc、Cingulate Inc、Celularity Inc C/Wts 16/07/2026 涨幅较大,Revelation Biosciences Inc、Neurobo Pharmaceuticals Inc、Clearmind Medicine Inc较为活跃,换手率分别为787.25%、580.29%、305.51%,振幅较大的相关个股有Ys Biopharma Co Ltd C/Wts 15/03/2028 、Cingulate Inc、Clearmind Medicine Inc,振幅分别为63.06%、55.81%、49.65%。Atreca Inc公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240201231447861d0508&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240201231447861d0508&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCEL","BK4139"],"gpt_icon":0},{"id":"2407357791","title":"Atreca Inc盘中异动 早盘快速下跌7.78%报0.307美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407357791","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2407357791?lang=zh_cn&edition=full","pubTime":"2024-01-30 22:31","pubTimestamp":1706625073,"startTime":"0","endTime":"0","summary":"北京时间2024年01月30日22时31分,Atreca Inc股票出现波动,股价快速跳水7.78%。截至发稿,该股报0.307美元/股,成交量13.07万股,换手率0.33%,振幅3.45%。Atreca Inc股票所在的生物技术行业中,整体跌幅为0.12%。Atreca Inc公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240130223113875d2e1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240130223113875d2e1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCEL"],"gpt_icon":0},{"id":"2406421631","title":"Atreca Inc盘中异动 股价大涨5.88%报0.234美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406421631","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2406421631?lang=zh_cn&edition=full","pubTime":"2024-01-25 01:03","pubTimestamp":1706115832,"startTime":"0","endTime":"0","summary":"北京时间2024年01月25日01时03分,Atreca Inc股票出现波动,股价大幅拉升5.88%。截至发稿,该股报0.234美元/股,成交量227.743万股,换手率5.75%,振幅8.87%。Atreca Inc股票所在的生物技术行业中,整体跌幅为0.51%。Atreca Inc公司简介:Atreca Inc 是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫疗法来治疗一系列实体瘤类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240125010352861cd531&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240125010352861cd531&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCEL","BK4139"],"gpt_icon":0},{"id":"2405212776","title":"Atreca Inc盘中异动 早盘股价大跌6.31%报0.244美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2405212776","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2405212776?lang=zh_cn&edition=full","pubTime":"2024-01-23 22:35","pubTimestamp":1706020511,"startTime":"0","endTime":"0","summary":"北京时间2024年01月23日22时35分,Atreca Inc股票出现异动,股价快速下跌6.31%。截至发稿,该股报0.244美元/股,成交量42.5161万股,换手率1.07%,振幅4.73%。Atreca Inc股票所在的生物技术行业中,整体跌幅为0.23%。其相关个股中,Evaxion Biotech As、Ensysce Biosciences Inc、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,Ensysce Biosciences Inc、Transcode Therapeutics Inc、Evaxion Biotech As较为活跃,换手率分别为279.11%、10.89%、6.72%,振幅较大的相关个股有Ensysce Biosciences Inc、Evaxion Biotech As、Sagimet Biosciences Inc,振幅分别为15.79%、15.57%、10.86%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401232235127a3dac9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401232235127a3dac9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCEL","BK4139"],"gpt_icon":0},{"id":"2405905589","title":"Atreca Inc盘中异动 股价大跌6.00%报0.282美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2405905589","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2405905589?lang=zh_cn&edition=full","pubTime":"2024-01-22 22:31","pubTimestamp":1705933884,"startTime":"0","endTime":"0","summary":"北京时间2024年01月22日22时31分,Atreca Inc股票出现波动,股价急速跳水6.00%。截至发稿,该股报0.282美元/股,成交量213.237万股,换手率5.38%,振幅0.93%。Atreca Inc股票所在的生物技术行业中,整体涨幅为0.12%。其相关个股中,Sagimet Biosciences Inc、Cadrenal Therapeutics Inc、Dianthus Therapeutics Inc涨幅较大,Sagimet Biosciences Inc、Tc Biopharm Plc、Transcode Therapeutics Inc较为活跃,换手率分别为34.82%、24.56%、20.33%,振幅较大的相关个股有Conduit Pharmaceuticals Inc、Sagimet Biosciences Inc、Tenax Therapeutics Inc,振幅分别为22.73%、16.57%、10.24%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012222312481d79dd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012222312481d79dd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCEL","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atreca.com","description":"Atreca, Inc.于2010年6月11日在特拉华州注册成立。该公司是一家生物制药公司,利用其差异化平台发现和开发新型抗体免疫治疗剂,以治疗多种实体肿瘤类型。该公司的主要候选产品ATRC-101是一种临床前开发的单克隆抗体,具有新的作用机制和源自使用其发现平台鉴定的抗体的靶标。自成立以来,公司主要从事研发,筹集资金,建立管理团队和建立知识产权组合。","exchange":"PINK","name":"Atreca, Inc.","nameEN":"Atreca, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atreca, Inc.(BCEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atreca, Inc.(BCEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atreca, Inc.,BCEL,Atreca, Inc.股票,Atreca, Inc.股票老虎,Atreca, Inc.股票老虎国际,Atreca, Inc.行情,Atreca, Inc.股票行情,Atreca, Inc.股价,Atreca, Inc.股市,Atreca, Inc.股票价格,Atreca, Inc.股票交易,Atreca, Inc.股票购买,Atreca, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atreca, Inc.(BCEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atreca, Inc.(BCEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}